Atilla Yıldırım

8PUBLICATIONS

157CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jul 15, 2026

Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study.

|Jun 26, 2026

Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study.

|May 27, 2026

First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis.

|Mar 28, 2026

Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group.

Sedat Yıldız, Hacer Demir, Talha Özüdoğru

|Mar 26, 2026

Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO).

Erman Akkus, Mehmet Kayaalp, Müzeyyen Aslı Ergözoğlu

|Nov 27, 2025

Altered Apoptosis in Endometriosis Compared with Ovarian Carcinoma.

Ozgur Ozdemir, Atila Yildirim, Yavuz Tekelioglu

Pageof 2

Frequent Collaborators

Elif Şahin

Esra Aşık

Sedat Biter

Ertugrul Bayram

Suheda Atas Ipek

Meltem Baykara

Ferhat Ekinci

Seda Jeral Evinc

Mehmet Kayaalp

Hatime Arzu Yasar

Frequent Collaborators

Elif Şahin

Esra Aşık

Sedat Biter

Ertugrul Bayram